With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...

As a doctor at Al-Aqsa Hospital, I saw what a collapse in the ceasefire could mean—and what can happen when a patient is ...

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been ...

The following is a summary of "12-month outcomes of pulsed-field ablation with a variable-diameter circular catheter for ...

Miniaturized pacemakers were successfully implanted in infants and neonates requiring pacing and performed reliably until ...

During a live event, Thach-Giao Truong, MD, moderated a discussion on treating a 78-year-old patient with metastatic melanoma ...

Heart conditions can be difficult to diagnose, often requiring specialised tools to provide a clear picture of a patient’s heart health. Among the most effective methods is the echo test for heart, ...

Theratechnologies (THTX) presented data highlighting the limitations of using body mass index alone in assessing cardiovascular risk in people ...

Theratechnologies Inc. ("Theratechnologies” or the "Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical ...

India: A recent study conducted in a high-endemic region highlights the role of chest X-rays (CXR) in identifying ...

Bank of New York Mellon Corp lowered its position in Artivion, Inc. (NYSE:AORT – Free Report) by 0.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the ...